Skip to main content

Palo Alto clinical trial software startup Medable joins unicorns with $304M funding

The nine-year old Palo Alto startup has now raised about $475 million in four fundings in the past 18 months.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.